Attendee search 

Alira Health is an integrated healthcare consulting firm and fully registered investment bank that provides execution and transaction services, management, regulatory and clinical advisory services and operates in US, EU and Japan with 12 offices.

Our advantage lies in a team of Doctors, Bankers, Scientists and Management Consultants that armed with field specific knowledge make a difference when it comes to find and exploit pathways of growth in the healthcare market.

We work for large medtech, big pharma, biotech companies, digital health, and healthcare providers covering the whole healthcare value chain and we are proudly recognized at a top 8 consulting firms globally in the healthcare market and among the best consulting firms according to Forbes.

Max Zeller Söhne AG specialises in the development, production and marketing of phyto-pharmaceuticals with clinically proven efficacy, safety and tolerability. 

Zeller is a leader in the Swiss market for phyto-pharmaceuticals and one of the few companies that controls the entire value chain from seed to finished product. At the Zeller sites in Romanshorn and Uttwil (VitaPlant), there are 135 employees in diverse disciplines such as biology, agriculture, process engineering, pharmacy and medicine. Patients benefit from Zeller’s phyto-pharmaceuticals both in Switzerland and worldwide.

Alfasigma is an Italian pharmaceutical company set up in May 2015 as result of an industrial partnership between two important pharma groups in Italy, Alfa Wassermann and Sigma-Tau. Alfasigma is ranked among the top five players in the pharmaceutical sector in Italy both in terms of Rx and OTC products with a total consolidated turnover of 1,1 billion Euro in 2017 and an headcount of 2.800 employees. Outside Italy, the new company operates directly in 16 countries among which USA, China, Russia, India and most European countries. Alfasigma has a wide range of products on the market in the following therapeutic areas: Gastrointestinal, Vascular, Muscoskeletal/Rheumathology, Cardiovascular, Metabolic, Respiratory. Alfasigma is also focused on research and development, including biotechnological research. Alongside R&D, also Manufacturing is a field where Alfasigma is strongly active with three production plants in Italy out of which the Alanno's plant operating as CMO.

Ethypharm is a rapidly growing specialty pharma company with nascent commercial operations, an expanding portfolio of marketed products, a unique drug development expertise and a broad and advanced pipeline.

Ethypharm now incorporating Martindale Pharma of the UK focuses on pain management and treatment for addiction, particularly opioids and alcohol use disorder; with the current short-term goal to commercialize its own or in-licensed drugs in a number of European countries.

In other therapeutic areas, mainly oncology, Ethypharm has a strong capability in developing and manufacturing specific and "complex" drug formulations in order to market them through global or local partners.

Ethypharm’s headquarters are located in Paris, France and has a very strong affiliate in the UK, it owns two manufacturing plants in France, one in China, and an affiliate in the USA.
 
Ethypharm is actively seeking:

• Licensing-in/acquisition opportunities in pain and addiction (to opioids, alcohol, tobacco) , critical care, complex generics, brands, late stage NCEs, Steriles/Injectables, Hospital products);

Specialized Pharma M&A Boutique operating since 1991 globally